US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

44.72

-1.0401-2.27%

Volume:1K

Turnover:65.75K

Market Cap:5.59M

PE:- -

High:44.72

Open:44.72

Low:44.72

Close:45.76

52wk High:45.88

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:1.63

T/O Rate:1.18%

Dividend:0.62

Dividend Rate:1.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims

CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

Regeneron’s Pasatru granted FDA approval for FOP

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Sweden's Medivir Q2 Turnover Falls

Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement

Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference

Regeneron Announces Investor Conference Presentations

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/TBXU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":44.7199,"timestamp":1788540555022,"preClose":45.76,"halted":0,"volume":1470,"delay":0,"changeRate":-0.02272945804195794,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Trading","change":-1.0401,"latestTime":"09-04 12:57:22 EDT","open":44.7199,"high":44.7199,"low":44.7199,"amount":65754.49062000001,"amplitude":0,"askPrice":44.76,"askSize":300,"bidPrice":44.7,"bidSize":300,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788552000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":45.76,"sharesOutstanding":100001,"nav":45.771,"aum":5721480.2,"dividendRate":0.013904,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":45.76,"preClose":45.76,"latestTime":"18:10 EDT","volume":55,"amount":2564.41,"timestamp":1788473433517,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.625914},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.625914,"shares":125000,"dividePrice":0.6218,"high":44.7199,"amplitude":0,"preClose":45.76,"low":44.7199,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":44.7199,"eps":0,"divideRate":0.013904,"volume":1470,"delay":0,"ttmEps":0,"open":44.7199,"prevYearClose":31.065,"prevWeekClose":42.5761,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":42.5761,"twentyDayClose":36.5847,"sixtyDayClose":28.1639},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661260437","title":"Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260437?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:58","pubTimestamp":1787313533,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against biotechnology company Regeneron ($REGN) on July 16, which could put further pressure on its troubled share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823434740.USD","LU2237438978.USD","FWD","LU0289739699.SGD","LU2362541273.HKD","IEIH","LU2106854487.HKD","FHLC","BK4139","AGNG","LU0320765992.SGD","LU0053666078.USD","LU2023250504.SGD","REGN","LU1917777945.USD","IBB","RSPH","BBP","LU0882574055.USD","LU2089984988.USD","BK4585","BBH","LU0114720955.EUR","LNGR","BK4588","LU0889565916.HKD","XT","LU2362540622.SGD","TBXU","LU0109394709.USD","LU2468319806.SGD","JDOC","LU0058720904.USD","LU1974910355.USD","LU0823416689.USD","SYNB","DARP","IBBQ","LU0823434583.USD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302932","title":"CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302932","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302932?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:07","pubTimestamp":1787263635,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals ( ($HK:2616) ) just unveiled an announcement. CStone Pharmaceuticals has secured rapid investigational new drug approval in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","IND","NETL","PSIL","ADC","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923014","title":"Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923014?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258134,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong long term returns over the past five years, yet current valuation checks and market multiples still point to the shares screening as undervalued. With recent news flow focused on its HIV and oncology franchises and on legal protection of its U.S. drug pricing, investors are weighing how much of this is already reflected in the price.\n\nGilead Sciences has returned 148.1% over the past five years, which puts recent valuation questions in the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CDIG","IE00BSNM7G36.USD","MEDI","BMED","IE00BKVL7J92.USD","IE0002270589.USD","LU0320765992.SGD","LU1057294990.SGD","LU0114720955.EUR","DAPP","LU0965508806.USD","LU1037948897.HKD","LU2089984988.USD","LU1778281490.HKD","LU0965509010.AUD","LU2112291526.USD","LU1066051498.USD","BK4585","TMED","BK4550","LU2468319806.SGD","LU0823416689.USD","SG9999015986.USD","BBH","LU2087621335.USD","BK4588","LU1430594728.SGD","LU0889565916.HKD","LU0289739699.SGD","SG9999015978.USD","TBXU","SG9999015945.SGD","TSPA","IBBQ","LU0861579265.USD","LU1934455863.HKD","BK4566","LU1037948541.HKD","IE00B19Z3581.USD","LU0965509283.SGD","TACU","GILD","BIB","IE00B19Z3B42.SGD","LU1934455194.USD","LU0122379950.USD","IBB","LU0109394709.USD","LU1934455277.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232279","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232279?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a seven-day winning streak.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 286,153 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU1066051498.USD","BMED","LU0320765992.SGD","LU1674673428.USD","LU0889565916.HKD","LU0234570918.USD","IBB","IE00BSNM7G36.USD","BK4585","LU0965509283.SGD","SG9999015986.USD","MEDI","LU0109394709.USD","BK4139","LU0965509101.SGD","IE0002270589.USD","LU1934455194.USD","BK4566","IE00B19Z3B42.SGD","SG9999015952.SGD","LU1585245621.USD","SG9999015978.USD","LU1778281490.HKD","IE00B3T34201.USD","SG9999015945.SGD","LU2089984988.USD","LU1023059063.AUD","IBBQ","LU0861579265.USD","LU1430594728.SGD","BIB","LU0823416689.USD","LU1037948541.HKD","LU1934455277.USD","LU2324357040.USD","GILD","LU0965509010.AUD","TBXU","BBH","IE00B19Z3581.USD","IE00BKVL7J92.USD","BK4532","LU1061106388.HKD","LU1037948897.HKD","LU1057294990.SGD","LU1571399168.USD","LU0122379950.USD","LU2112291526.USD","TMED","BK4550","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU1934455863.HKD","LU2468319806.SGD","LU0965508806.USD","LU0289739699.SGD","BK4583","LU1674673691.USD","LU0882574055.USD","IE00B7SZLL34.SGD","LU1839511570.USD","LU2087621335.USD","LU0058720904.USD","BK4588","BK4578","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232427","title":"Moderna Inc. Stock Slips 23.5%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232427?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU1430594728.SGD","LU0965509010.AUD","LU2112291526.USD","LGHT","GILD","BK4550","LU1934455194.USD","IDNA","LU1585245621.USD","IE00B3T34201.USD","LU1674673428.USD","LU0114720955.EUR","IBBQ","IBB","IE00BSNM7G36.USD","LU0058720904.USD","GNOM","BK4532","LU2324357040.USD","LU1674673691.USD","BK4578","SG9999015952.SGD","BK4566","LU0882574055.USD","LU1023059063.AUD","MEDI","WDNA","LU1066053197.SGD","MRNX","LU1037948541.HKD","IE00B7SZLL34.SGD","MRNA","LU1839511570.USD","MRNY","LU0823416689.USD","BMED","LU1778281490.HKD","LU0109394709.USD","TMED","BK4548","IE00B19Z3B42.SGD","SG9999015945.SGD","BBH","BK4139","TBXU","BK4533","LU2468319806.SGD","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323699","title":"Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323699","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323699?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243431,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 2b study A Phase 2b, Open-label Study to Evaluat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","BK4585","LU0234570918.USD","IBBQ","LU1093756168.USD","VERX","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU1815336091.USD","IE00B19Z9P08.USD","LU1069344957.HKD","IE00BJJMRZ35.SGD","PBE","LU1674673428.USD","LU0432979614.USD","LU0289739699.SGD","LU2362540622.SGD","TBXU","LU2089984988.USD","LU2468319806.SGD","LU0566484027.USD","LU2456880835.USD","BK4139","IDNA","LU0079474960.USD","VRTX","IE00B894F039.SGD","SGXZ57979304.SGD","IBB","IE0009355771.USD","LU2362541273.HKD","SG9999001176.SGD","LU2237438978.USD","LU0757428866.USD","LU0889565916.HKD","BIB","LU2324357040.USD","LU0256863811.USD","GNMX","BK4567","SG9999013999.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU2417539215.USD","BK4588","LU2362541513.USD","IE0002141913.USD","LU1674673691.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287604","title":"Regeneron’s Pasatru granted FDA approval for FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287604?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:20","pubTimestamp":1787232025,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease flare-ups i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-pasatru-granted-fda-approval-for-fop-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","RSPH","MRNX","MEDI","LABU","FRTY","TBXU","GDOC","NVIB","SYNB","LFSC","PSCH","BK4588","BBP","MRNY","IEIH","XLVX","BK4585","TECB","IYH","IDNA","IBB","PINK","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728971","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728971?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Glaukos (GKOS) and Ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU1035775433.USD","BK4533","GKOS","LU0109394709.USD","TBXU","LU2468319806.SGD","LU2462157665.USD","LU0432979614.USD","BK4139","LU2089984988.USD","LU2362540622.SGD","IE0002141913.USD","IBB","IE00B2B36J28.USD","IE0009354923.USD","BK4548","LU1674673691.USD","LU0417517546.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1093756168.USD","LU1878469433.USD","LU2362541513.USD","SG9999001176.SGD","IE00BZ9MQY76.HKD","BK4585","LU0289739699.SGD","BK4532","BBH","LU0079474960.USD","LU0889565916.HKD","LU1778281490.HKD","GNMX","IDNA","LU1585245621.USD","LU2236285917.USD","IE0009355771.USD","BK4588","LU0061475181.USD","LU1069344957.HKD","LU1430594728.SGD","SGXZ57979304.SGD","BIB","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU2324357040.USD","IE00B19Z9Z06.USD","LU2237438978.USD","SG9999013999.USD","LU0320765992.SGD","LU0823416689.USD","LU0234570918.USD","SG9999001176.USD","IE00B894F039.SGD","IBBQ","IE00B19Z3B42.SGD","LU2065731478.USD","PBE","LU1674673428.USD","IE00B4R5TH58.HKD","VRTX","IE00B19Z9P08.USD","LU2417539215.USD","LU2362541273.HKD","LU2456880835.USD","IE0002270589.USD","LU1093756325.SGD","BK4567","BK4082","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","BK1521","LU2112291526.USD","LU0122379950.USD","BK1191","01177","BK4599","PBE","IBBQ","IE00BJT1NW94.SGD","IBB","BK1515","IE00B4R5TH58.HKD","LU2089984988.USD","LU0058720904.USD","LU1057294990.SGD","BK4566","LU1023059063.AUD","LU1571399168.USD","SG9999001440.SGD","IE00BZ08YR35.GBP","LU2242652126.USD","BK4588","IE00BJJMRZ35.SGD","PJP","LU2242646821.SGD","AMGN","LU0889565916.HKD","LU2468319806.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU1061106388.HKD","BK4581","BK4534","BBH","BK4585","HK0000165453.HKD","IE00BZ08YT58.USD","LU0868494617.USD","BK4139","IE0002141913.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","TBXU","BK1589","BK4533","LU0320765992.SGD","IE00BZ08YS42.EUR","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660340609","title":"Sweden's Medivir Q2 Turnover Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340609","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340609?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:41","pubTimestamp":1787208103,"startTime":"0","endTime":"0","summary":"Sweden's Medivir Q2 turnover fallsOverviewSweden drug developer's Q2 net turnover declined yr/yr, EBITDA loss narrowedCompany completed SEK 140 mln share issue to fund rare bone disease drug developme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H07I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLEL","IBBQ","LU2106854487.HKD","LU1366192091.USD","LU1720051108.HKD","LU2362541273.HKD","LU0289739699.SGD","LU0069063385.USD","LU0114720955.EUR","LU0053666078.USD","LU0058720904.USD","LU0320765489.SGD","LU0289739343.SGD","LU2468319806.SGD","LU2357305700.SGD","REGN","LU0823434740.USD","LU2272731782.SGD","LU2272731600.USD","LU2322448791.USD","LU0208291251.USD","LU1917777945.USD","LU2023250504.SGD","LU2322448957.HKD","LU0823416689.USD","IBB","LU1720051017.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD","LU1974910355.USD","LU2272731865.HKD","LU2362541513.USD","LU2362540622.SGD","LU1992135472.HKD","FLEX","LU1303367103.USD","LU2089984988.USD","LU2473716301.USD","BK4585","BBH","LU0057025933.USD","TBXU","LU0823434583.USD","LU0511384066.AUD","LU2237438978.USD","BK4512","BK4588","LU0963586101.USD","LU0289960550.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660028408","title":"Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028408","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660028408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:43","pubTimestamp":1787200984,"startTime":"0","endTime":"0","summary":"Glenmark Pharmaceuticals Limited ( ($IN:GLENMARK) ) just unveiled an announcement. Glenmark Pharmaceuticals has secured U.S. FDA approval for its F...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","IBB","LFSC","PSCH","LABU","GDOC","SYNB","IDNA","MEDI","GNMX","IEIH","MRNX","BK4585","TECB","RSPH","MRNY","BMED","FRTY","BK4588","TBXU","NVIB","PINK","BBP","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002270589.USD","IE00BFTCPJ56.SGD","BK4023","LU1778281490.HKD","LU0889565916.HKD","IE00B19Z9P08.USD","LU2456880835.USD","IE0009355771.USD","GNMX","VERX","IE00B19Z9Z06.USD","LU1093756325.SGD","IBBQ","IE00BJJMRZ35.SGD","LU2362541513.USD","SGXZ57979304.SGD","LU2089984988.USD","BK4588","BIB","IDNA","BK4585","IBB","PBE","VRTX","IE0002141913.USD","IE00BZ9MQY76.HKD","LU0256863811.USD","SG9999001176.SGD","TBXU","LU0289739699.SGD","IE00B19Z3581.USD","LU2468319806.SGD","LU2462157665.USD","BK4532","LU0234570918.USD","LU2236285917.USD","BK4533","LU0320765992.SGD","LU1035775433.USD","LU1093756168.USD","LU2237438978.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0566484027.USD","LU0061475181.USD","SG9999013999.USD","LU0058720904.USD","SG9999001176.USD","BBH","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660796854","title":"Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660796854","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660796854?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:10","pubTimestamp":1787181028,"startTime":"0","endTime":"0","summary":"Telix swings to H1 FY26 net profit of US$38 million; revenue rises 22% to US$477 millionTelix Pharmaceuticals reported H1 2026 revenue of US$477 million, up 22% year over year.Net profit swung to US$3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLbYKwmX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU0823434583.USD","LU2468319806.SGD","REGN","LU2237438978.USD","LU0289739699.SGD","IBB","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU2089984988.USD","BK4588","LU2362541513.USD","BK7067","LU2023250504.SGD","BBH","LU0882574055.USD","BK4139","LU1974910355.USD","LU2362540622.SGD","TBXU","LU0053666078.USD","LU0889565916.HKD","LU0823434740.USD","LU0823416689.USD","BK4585","LU0114720955.EUR","LU2362541273.HKD","TLX.AU","LU0109394709.USD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282476","title":"Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282476","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:31","pubTimestamp":1787178660,"startTime":"0","endTime":"0","summary":"Profit margin %                           28 %       24 %      26 %      23 %. Adjusted EBITDA %                         18 %       13 %      15 %      11 %.   See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2026-- Net revenue increased $1.0 million over prior period while G&A expenses. -- Profit margin improved to 28.4% of net revenue, up from 24.3% in 2025.-- Adjusted EBITDA increased by $2.8 million, or 43.8%, compared to 2025,with Adjusted EBITDA growth in both the Environmental Consulting and. -- Returned to profitability with net income of $1.0 million, representing a. -- Free cash flow increased to $4.6 million from $1.3 million in Q2 2025.HIGHLIGHTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-- Environmental Consulting net revenue increased by 7.8% compared to H1. -- G&A expenses were reduced by 6.5% compared to H1 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","IE00B19Z3581.USD","BBH","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0417517546.SGD","IBB","LU0061475181.USD","BK4139","LU2456880835.USD","PBE","BK4532","VERX","LU1069344957.HKD","BK4533","LU0079474960.USD","SG9999013999.USD","SPHQ","LU2462157665.USD","LU0823416689.USD","SG9999001176.SGD","LU0109394709.USD","BIB","LU0889565916.HKD","IE00B4R5TH58.HKD","IDNA","LU0256863811.USD","LU1674673428.USD","IE00BJT1NW94.SGD","LU1674673691.USD","LU2089984988.USD","TBXU","VRTX","IE0002141913.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00B19Z9P08.USD","BK4588","IE00BJJMRZ35.SGD","IBBQ","GNMX","SG9999001176.USD","LU0432979614.USD","LU1815336091.USD","LU0058720904.USD","IE00B2B36J28.USD","LU2468319806.SGD","IE0009355771.USD","LU1035775433.USD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660737004","title":"Crinetics Faces Shareholder Challenges to Vertex Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660737004","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660737004?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171563,"startTime":"0","endTime":"0","summary":"An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics agreed to be acquired by Vertex Pharmaceuticals v...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU1778281490.HKD","IE00B19Z9P08.USD","LU1585245621.USD","LU2456880835.USD","IE0009355771.USD","GNMX","VERX","IE00B894F039.SGD","IE00B19Z9Z06.USD","BK4567","LU2324357040.USD","IBBQ","IE00BJJMRZ35.SGD","LU2362541513.USD","SGXZ57979304.SGD","LU2089984988.USD","BK4588","BIB","IDNA","BK4585","IBB","LU1674673691.USD","PBE","VRTX","IE0002141913.USD","IE00BZ9MQY76.HKD","LU0256863811.USD","LU0432979614.USD","BK4139","IE00B2B36J28.USD","SG9999001176.SGD","LU0289739699.SGD","TBXU","IE00B19Z3581.USD","LU2462157665.USD","LU0234570918.USD","LU1069344957.HKD","BK4533","LU0320765992.SGD","LU1035775433.USD","LU1093756168.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0566484027.USD","SG9999013999.USD","LU2417539215.USD","SG9999001176.USD","BBH","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473115","title":"Moderna Inc. Stock Rallies 177.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. sailed 177.0% to $174.38 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $85.60, which the company achieved on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Gilead Sciences Inc. rose 2.90% to $147.60.Trading volume totaled 187.3 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0320765992.SGD","LU0965508806.USD","IDNA","LGHT","TBXU","BK4588","GILD","MEDI","LU1934455194.USD","BK4583","IE00B19Z3B42.SGD","BMED","LU1585245621.USD","BIB","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU0122379950.USD","LU1934455277.USD","TMED","IBB","SG9999015978.USD","LU0889565916.HKD","LU1674673428.USD","BBH","IE00B7SZLL34.SGD","MRNY","IBBQ","LU0965509101.SGD","GNOM","LU1430594728.SGD","BK4548","LU0965509283.SGD","IE00BKVL7J92.USD","LU1934455863.HKD","BK4139","MRNX","SG9999015952.SGD","LU2324357040.USD","LU0965509010.AUD","LU1571399168.USD","IE0002270589.USD","LU0234570918.USD","IE00BZ1G4Q59.USD","MRNA","LU1778281490.HKD","BK4533","LU0861579265.USD","WDNA","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473673","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473673","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473673?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:15","pubTimestamp":1787170546,"startTime":"0","endTime":"0","summary":"• Vertex stock surged to record highs following a rival's clinical trial failure.\n• Q2 revenue beat estimates, and the company raised its full-year guidance.\n• Analysts issued bullish ratings with an average price target of $563.25.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262119122-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1035775433.USD","IE0002141913.USD","GNMX","LU2362540622.SGD","IE0002270589.USD","LU2236285917.USD","LU0256863811.USD","LU2362541513.USD","LU2237438978.USD","BBH","LU0432979614.USD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU0320765992.SGD","LU2324357040.USD","LU2468319806.SGD","IE00B894F039.SGD","LU1585245621.USD","BK4533","LU0234570918.USD","LU0417517546.SGD","LU2089984988.USD","SG9999001176.SGD","SG9999001176.USD","LU1674673691.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU1069344957.HKD","IE00BFTCPJ56.SGD","LU0061475181.USD","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","LU2417539215.USD","IE00B19Z9P08.USD","SG9999013999.USD","BK4532","LU1093756325.SGD","TBXU","LU0058720904.USD","BIB","LU0823416689.USD","IE00B19Z9Z06.USD","LU0289739699.SGD","BK4585","LU2462157665.USD","IDNA","LU0079474960.USD","PBE","IBB","SGXZ57979304.SGD","BK4588","IE00B2B36J28.USD","LU2362541273.HKD","IE00B19Z3581.USD","LU2456880835.USD","BK4139","IE00BZ9MQY76.HKD","IE0009355771.USD","LU0109394709.USD","LU0889565916.HKD","VRTX","LU1674673428.USD","LU1778281490.HKD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660647872","title":"Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2660647872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660647872?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:06","pubTimestamp":1787169960,"startTime":"0","endTime":"0","summary":"Regeneron to webcast management presentation at Wells Fargo Healthcare ConferenceRegeneron to present at the 2026 Wells Fargo Healthcare Conference on Sept. 9, 2026 at 8:45 a.m. ET.Management to appea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL2xh7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BK4585","IBBQ","IE00BQXX3F31.USD","SG9999014039.USD","BCDF","LU2023250504.SGD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","SG9999014013.SGD","LU2362540622.SGD","LU0289739699.SGD","TBXU","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU0314104364.USD","LU2468319806.SGD","BK4139","LU0114720955.EUR","BK4112","IBB","IE00BQXX3D17.EUR","LU2106854487.HKD","LU2362541273.HKD","IE00BQXX3C00.GBP","LU1917777945.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU0823416689.USD","LU2237438978.USD","NDAQ","LU2210150020.SGD","LU0889565916.HKD","REGN","LU0823434740.USD","IE00B3QW5Z07.USD","LU0320765992.SGD","LU0053666078.USD","BK4588","LU0058720904.USD","IE00BKPKM429.USD","LU2095319765.USD","LU2362541513.USD","LU0109394709.USD","LU1974910355.USD","SG9999014021.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473213","title":"Regeneron Announces Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473213","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473213?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:05","pubTimestamp":1787169900,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Aug.  19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347966/0/en/regeneron-announces-investor-conference-presentations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU0320765992.SGD","LU1917777945.USD","LU0889565916.HKD","IBB","BK4585","LU2023250504.SGD","LU0109394709.USD","BK4139","LU0823434583.USD","LU0053666078.USD","LU2106854487.HKD","REGN","LU2237438978.USD","LU2089984988.USD","IBBQ","LU2362541273.HKD","LU0823416689.USD","TBXU","BBH","LU2362540622.SGD","LU2362541513.USD","LU2468319806.SGD","LU0289739699.SGD","LU0882574055.USD","LU1974910355.USD","LU0823434740.USD","LU0058720904.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660742032","title":"Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660742032","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660742032?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:27","pubTimestamp":1787164025,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  has received approval from the US Food and Drug Administration for Pasatru to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, or FOP, the drugmaker said Wednesday.FOP is an ultra-rare genetic disorder in which rogue bone formation progressively infiltrates muscles, tendons, ligaments and other connective tissues, causing loss of mobility and potentially making basic activities such as walking, eating and breathing difficult, the company said.The approval was based on phase 3 OPTIMA trial results showing Pasatru reduced new heterotopic ossification lesions by 90% at the 10 mg per kg dose and 94% at the 3 mg per kg dose versus placebo at 56 weeks, the company said.Clinician-assessed flare-ups fell 88% with the 10 mg/kg dose and 15% with the 3 mg per kg dose, the company said.Price: 840.95, Change: +30.71, Percent Change: +3.79","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0823434740.USD","LU0058720904.USD","BK4139","LU0109394709.USD","IBBQ","LU2106854487.HKD","REGN","LU2362541273.HKD","LABU","LU2362540622.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0882574055.USD","BK4588","LU0320765992.SGD","LU0053666078.USD","LU0823416689.USD","TBXU","LU0889565916.HKD","LU2089984988.USD","IBB","BK4585","LU2237438978.USD","LU0289739699.SGD","LU1917777945.USD","BBH","LU0823434583.USD","LU1974910355.USD","LU2023250504.SGD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}